Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Elects Medicago CEO Andy Sheldon as Board Chairman; Reports Results of the Annual General Meeting (AGM)

HALIFAX, NOVA SCOTIA--(Marketwired - April 15, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
April 13, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors

HALIFAX, NOVA SCOTIA--(Marketwired - April 13, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
April 11, 2016 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present New Pre-Clinical Data at the 2016 AACR Annual Meeting

HALIFAX, NOVA SCOTIA--(Marketwired - April 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy...
April 07, 2016 07:05 ET | Source: Immunovaccine Inc.;Leidos

Immunovaccine and Leidos Join Forces to Develop a Zika Virus Vaccine Candidate

HALIFAX, NOVA SCOTIA and RESTON, VIRGINIA--(Marketwired - April 7, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and...
March 29, 2016 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces 2015 Year-End Results

HALIFAX, NOVA SCOTIA--(Marketwired - March 29, 2016) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced its financial and...
March 15, 2016 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Management Team Changes

HALIFAX, NOVA SCOTIA--(Marketwired - March 15, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
March 03, 2016 09:00 ET | Source: Immunovaccine Inc.

Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform

HALIFAX, NOVA SCOTIA--(Marketwired - March 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy...
January 11, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces U.S. FDA, Health Canada Clearance to Initiate Phase 1b Clinical Trial for DPX-Survivac in Combination with Incyte's IDO1 Inhibitor Epacadostat in Recurrent Ovarian Cancer

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
January 07, 2016 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Participate in Panel Discussion at Biotech Showcase 2016

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 7, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
December 17, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Publishes Findings Unique to DepoVax(TM) Technology on Potential of MRI Scans to Predict and Optimize Cancer Vaccine Response

HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 17, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...